Similar content being viewed by others
This article is cited by
-
Ototoxicity in Patients of Advanced Head and Neck Malignancies Receiving Chemoradiation Versus Radiation Alone: Comparative Study
Indian Journal of Otolaryngology and Head & Neck Surgery (2022)
-
Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin
Supportive Care in Cancer (2021)
-
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study
The Pharmacogenomics Journal (2020)
-
The genetic vulnerability to cisplatin ototoxicity: a systematic review
Scientific Reports (2019)
-
Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin
The Pharmacogenomics Journal (2017)